No, B12 injections are licensed medicines used to treat confirmed vitamin B12 deficiency, whilst lipotropic injections are unlicensed combinations marketed for weight loss without robust clinical evidence
However, glatiramer acetate, another MS treatment has not been found to affect vitamin B12 levels in MS patients [148]
The Phase 2b trial used subcutaneous injection, not oral formulation
It also carries the greatest heart-rate, gastrointestinal, over-loss, and lean-mass burden. Tirzepatide has a roughly 5-day half-life
What did the FDA committee members decide
The treatments effectiveness is closely tied to your commitment to a healthy diet and regular exercise